South Africa intensifies fight against tuberculosis
Challenges in meeting UN Sustainable Development Goals for tuberculosis include late diagnosis, high HIV co-infection, and poverty-related barriers to care.
Research faces funding crisis after NIH grant cuts
South African researchers face significant funding cuts from the US National Institutes of Health (NIH), jeopardising critical HIV/AIDS and TB research.
FDA warns Aspen Pharmacare over eye drop production standards
The US FDA has warned Aspen Pharmacare, Africa's largest drugmaker, citing breaches in manufacturing standards for eye drops produced at its Gqeberha facility.
SA confident of HIV treatment goals despite aid cuts
Motsoaledi assures Parliament that the nation remains on track to meet its HIV treatment targets despite cuts in US aid, showing the country's self-reliance.
Pharmaceutical industry fights to shield drugs from tariffs
Pharmaceutical companies urge the Trump administration and EU to exclude medical goods from tariff wars, warning of potential price hikes and access barriers.
NHI’s absence from budget raises questions about its future
The Finance Minister's Budget 2025 speech omits mentioning NHI despite references in accompanying documents, highlighting financial and practical challenges.